Prostate‐specific antigen testing by income, age, and region: a nationwide population‐based study
Аннотация
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in Sweden without a prior diagnosis of prostate cancer between 2000 and 2023. The proportion of men that underwent at least one PSA test between 1 January and 31 December was estimated each year overall and stratified by income (bottom 25%, middle 50%, top 25%), age, and region of residence. Results The PSA testing was higher in the top income group across all ages. In 2019, prior to the coronavirus disease 2019 pandemic, overall PSA testing was 17% and ranged from 13% in the bottom income group to 20% in the top. Overall, PSA testing and income‐related differences in PSA testing varied substantially between regions. In 2019, PSA testing varied between 12% and 20% between regions and difference in PSA testing between men with lowest and highest income ranged from 3.6% to 10% across regions. In regions with high PSA testing the difference in testing according to income was not smaller than in regions with little testing. PSA testing was higher among men aged 80–90 years (22%) than among men aged 50–59 years (13%). Conclusions Men in the highest income group underwent PSA testing more frequently, and many older men were tested despite guideline recommendations to the contrary. This pattern of opportunistic, unstructured testing not only leads to inequity but also high rates of testing in men at greatest risk of harm and least likely to benefit. These findings underscore the need for organised prostate cancer testing.